NVAX Sep 2024 4.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 10:40AM EDT
Loading interactive chart…
- PR Newswire
Novavax to Participate in 2024 Jefferies Global Healthcare Conference
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the 2024 Jefferies Global Healthcare Conference.
- Zacks
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- Barrons.com
Arbutus, Novavax See Activist Investor Action
Whitefort Capital wants biopharmaceutical firm Arbutus to stop issuing stock. Shah Capital ended a proxy campaign against biotech Novavax.
© 2024 Yahoo. All rights reserved.